Europe Cardiovascular Ultrasound Market 2022-2028

Europe Cardiovascular Ultrasound Market 2022-2028

MARKET OUTLOOK

Triton Market Research’s report on Europe’s cardiovascular ultrasound market estimates that it would grow in terms of revenue, with a CAGR of 6.03% in the forecast period from 2022 to 2028. Spain, Germany, France, Italy, the United Kingdom, and Rest of Europe are assessed in the market in this region.

Heart and circulatory diseases are responsible for nearly 25% of all deaths in the United Kingdom. Approximately 7.6 million individuals (4 million men and 3.6 million women) in the nation have reported having a heart or circulatory disease. The most common type of heart disease is coronary heart disease (CHD). It is a leading cause of cardiac arrests and resulting mortality in both men and women.

The alarming prevalence rate of these diseases has enhanced the demand for cardiovascular ultrasound devices in the UK. This has prompted key players, such as Siemens Healthineers, GE Healthcare, and others, to offer technologically advanced echocardiography machines to diagnose and examine these conditions efficiently.

CVDs are also becoming increasingly prevalent in France. These ailments are largely affecting the younger segments of the population, and are the second leading cause of mortality in the country, at present. According to the statistics, approximately 63,181 people in the nation died from (CHD) in 2020, accounting for 13.22% of total deaths.

This has accelerated the demand for cardiovascular ultrasound systems to effectively detect these illnesses on time and aid the treatment process. The increased adoption of these equipment is expected to foster the cardiovascular ultrasound market’s growth in the years to come.

COMPETITIVE OUTLOOK

A few eminent players in the cardiovascular ultrasound market include Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Clarius, Esaote S.p.A., Viatom Technology Co, Fujifilm Holdings Corporation, Dawei Medical, and Lanmage.